Form 8-K - Current report:
SEC Accession No. 0001213900-25-050984
Filing Date
2025-06-04
Accepted
2025-06-04 08:37:50
Documents
15
Period of Report
2025-05-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0244642-8k_synergy.htm   iXBRL 8-K 29848
2 CREDIT AGREEMENT, DATED AS OF MAY 30, 2025, BY AND AMONG SYNERGY CHC CORP. AS BO ea024464201ex10-1_synergy.htm EX-10.1 882589
3 PRESS RELEASE, DATED JUNE 4, 2025 ea024464201ex99-1_synergy.htm EX-99.1 4361
4 GRAPHIC ex99-1_001.jpg GRAPHIC 9284
  Complete submission text file 0001213900-25-050984.txt   1300804

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE snyr-20250530.xsd EX-101.SCH 3020
6 XBRL LABEL FILE snyr-20250530_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE snyr-20250530_pre.xml EX-101.PRE 22362
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0244642-8k_synergy_htm.xml XML 3528
Mailing Address 865 SPRING STREET WESTBROOK ME 04092
Business Address 865 SPRING STREET WESTBROOK ME 04092 615-939-9004
Synergy CHC Corp. (Filer) CIK: 0001562733 (see all company filings)

EIN.: 990379440 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42374 | Film No.: 251022011
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)